quantit evalu serum pancreat isoamylas cystic fibrosi amylas sera 20 patient cystic fibrosi pancrea cfp 17 pancreat insuffici pi 34 normal control subject separ pancreat salivari compon quantit electrophoret separ achiev polyacrylamid disc gel subsequ section gel column amylas content intern unit per liter iul obtain section insolubl blue starch substrat method mean total serum amylas cfp patient pi significantli lower control group highli signific decreas found pancreat isoamylas consid alon salivari isoamylas level remain essenti three patient cfp without pi demonstr higher normal pancreat amylas valu serum patient may earli stage progress involv pancrea increas releas amylas method electrophoret separ quantit serum amylas sensit effici allow simultan process multipl specimen result obtain agre previous publish ratio serum isoamylas method valuabl studi diseas exocrin pancrea salivari gland